Covered recipient · General Payments record
LAURI E BUDNICK
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Urogynecology and Reconstructive Pelvic Surgery
General Payments · PY2019–2025
$4,115.46
- Reported across 100 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $406.05 | 15 |
| Honoraria | $350.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teleflex LLC | $350.00 | 1 |
| ABBVIE INC. | $259.74 | 10 |
| Escala Medical Inc. | $102.11 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $22.99 | 1 |
| Provepharm Inc. | $21.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.23 | 01/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578332 | CMS |
| ABBVIE INC. | $27.16 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578334 | CMS |
| ABBVIE INC. | $24.32 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578336 | CMS |
| ABBVIE INC. | $27.76 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578338 | CMS |
| ABBVIE INC. | $25.77 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578340 | CMS |
| ABBVIE INC. | $25.18 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578342 | CMS |
| ABBVIE INC. | $24.72 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578344 | CMS |
| ABBVIE INC. | $27.52 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578346 | CMS |
| ABBVIE INC. | $29.14 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578348 | CMS |
| ABBVIE INC. | $22.94 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201578350 | CMS |
| Boston Scientific Corporation | $22.99 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212230386 | CMS |
| Escala Medical Inc. | $10.11 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1159561858 | CMS |
| Escala Medical Inc. | $53.00 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1159561892 | CMS |
| Escala Medical Inc. | $39.00 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1159561902 | CMS |
| Provepharm Inc. | $21.21 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188061151 | CMS |
| Teleflex LLC | $350.00 | 12/19/2025 | Honoraria | Undisputed | 06/30/2026 | 1242431426 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.